103RD GENERAL ASSEMBLY
State of Illinois
2023 and 2024
HB2631

 

Introduced 2/15/2023, by Rep. Marcus C. Evans, Jr.

 

SYNOPSIS AS INTRODUCED:
 
305 ILCS 5/5-5.12f new

    Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that for the purpose of removing barriers to the timely and equitable treatment of hepatitis C, prior authorization mandates and utilization management controls shall not be imposed under the fee-for-service and managed care medical assistance programs on any FDA-approved direct-acting antivirals for the treatment of hepatitis C that are listed as preferred on the Illinois Medicaid Preferred Drug List.


LRB103 26141 KTG 52498 b

 

 

A BILL FOR

 

HB2631LRB103 26141 KTG 52498 b

1    AN ACT concerning public aid.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Illinois Public Aid Code is amended by
5adding Section 5-5.12f as follows:
 
6    (305 ILCS 5/5-5.12f new)
7    Sec. 5-5.12f. Prescription drugs for hepatitis C virus; no
8prior approval mandates or utilization management controls.
9Notwithstanding any other provision of this Code to the
10contrary, for the purpose of removing barriers to the timely
11and equitable treatment of hepatitis C, prior authorization
12mandates and utilization management controls shall not be
13imposed under the fee-for-service and managed care medical
14assistance programs on any FDA-approved direct-acting
15antivirals for the treatment of hepatitis C that are listed as
16preferred on the Illinois Medicaid Preferred Drug List.